What amount sold does C2N JMK, Inc. report in Form D filings?

The latest linked filings report $10M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was C2N JMK, Inc.'s most recent SEC filing?

C2N JMK, Inc.'s most recent Form D filing was on 2025-08-06.

How many investors does C2N JMK, Inc. have?

The most recent Form D filing lists 2 investor(s).

What type of securities does C2N JMK, Inc. offer?

C2N JMK, Inc.'s SEC Form D filings indicate debt offerings.

C2N JMK, Inc.

CIK: 0002079558·Biotechnology·ST. LOUIS, MO·Corporation·Founded 2025

Reported Sold

$9,999,891

Total Filings

Identified Offerings

Last Filed

Aug 6, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Aug 6, 2025Form D — New notice

Reported sold: $9,999,891 · Target: $9,999,891

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$9,999,891

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jinzhu Yu

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 6, 2025	New	$9,999,891	$9,999,891	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Life Impact Partners 8 LLC

Biotechnology

Offering target: $5,000,000

Filed Nov 6, 2026